Shou S, Maolan A, Zhang D, Jiang X, Liu F, Li Y
Exp Hematol Oncol. 2025; 14(1):8.
PMID: 39871386
PMC: 11771031.
DOI: 10.1186/s40164-025-00597-9.
Li H, Zheng L, Hu N, Wang Z, Tao C, Wang Y
World J Gastroenterol. 2024; 30(9):1224-1236.
PMID: 38577190
PMC: 10989492.
DOI: 10.3748/wjg.v30.i9.1224.
Lefeuvre C, Le Guillou-Guillemette H, Ducancelle A
Int J Mol Sci. 2021; 22(24).
PMID: 34948447
PMC: 8707456.
DOI: 10.3390/ijms222413651.
In der Stroth L, Tharehalli U, Gunes C, Lechel A
Cancers (Basel). 2020; 12(8).
PMID: 32722302
PMC: 7464754.
DOI: 10.3390/cancers12082048.
Samadi F, Suhail S, Sonam M, Ahmad M, Chandra S, Saleem M
J Oral Maxillofac Pathol. 2019; 23(2):187-191.
PMID: 31516221
PMC: 6714254.
DOI: 10.4103/jomfp.JOMFP_83_19.
Identification of genes involved in the regulation of TERT in hepatocellular carcinoma.
Amisaki M, Tsuchiya H, Sakabe T, Fujiwara Y, Shiota G
Cancer Sci. 2018; 110(2):550-560.
PMID: 30447097
PMC: 6361581.
DOI: 10.1111/cas.13884.
HCV Induces Telomerase Reverse Transcriptase, Increases Its Catalytic Activity, and Promotes Caspase Degradation in Infected Human Hepatocytes.
Zhu Z, Tran H, Mathahs M, Moninger T, Schmidt W
PLoS One. 2017; 12(1):e0166853.
PMID: 28056029
PMC: 5215869.
DOI: 10.1371/journal.pone.0166853.
Nonalcoholic Steatohepatitis: Involvement of the Telomerase and Proinflammatory Mediators.
Serhal R, Hilal G, Boutros G, Sidaoui J, Wardi L, Ezzeddine S
Biomed Res Int. 2015; 2015:850246.
PMID: 26273651
PMC: 4529930.
DOI: 10.1155/2015/850246.
Common telomerase reverse transcriptase promoter mutations in hepatocellular carcinomas from different geographical locations.
Cevik D, Yildiz G, Ozturk M
World J Gastroenterol. 2015; 21(1):311-7.
PMID: 25574106
PMC: 4284350.
DOI: 10.3748/wjg.v21.i1.311.
DNAzyme-based probes for telomerase detection in early-stage cancer diagnosis.
Wang H, Donovan M, Meng L, Zhao Z, Kim Y, Ye M
Chemistry. 2013; 19(14):4633-9.
PMID: 23426940
PMC: 3755732.
DOI: 10.1002/chem.201204440.
Increased telomerase activity and hTERT expression in human salivary gland carcinomas.
Shigeishi H, Sugiyama M, Tahara H, Ono S, Bhawal U, Okura M
Oncol Lett. 2012; 2(5):845-850.
PMID: 22866138
PMC: 3408017.
DOI: 10.3892/ol.2011.354.
Establishment of functional telomerase immortalized human hepatocytes and a hepatic stellate cell line for telomere-targeting anticancer drug development.
Waki K, Anno K, Ono T, Ide T, Chayama K, Tahara H
Cancer Sci. 2010; 101(7):1678-85.
PMID: 20456367
PMC: 11159078.
DOI: 10.1111/j.1349-7006.2010.01576.x.
Targeted antitumor effect induced by hTERT promoter mediated ODC antisense adenovirus.
Wang W, Jin B, Li W, Xu C, Cui F, Liu B
Mol Biol Rep. 2009; 37(7):3239-47.
PMID: 19876766
DOI: 10.1007/s11033-009-9908-5.
Telomerase activity and hepatic functions of rat embryonic liver progenitor cell in nanoscaffold-coated model bioreactor.
Giri S, Nieber K, Acikgoz A, Pavlica S, Keller M, Bader A
Mol Cell Biochem. 2009; 336(1-2):137-49.
PMID: 19816756
DOI: 10.1007/s11010-009-0266-3.
Telomerase activity in tumor and remnant liver as predictor of recurrence and survival in hepatocellular carcinoma after resection.
Shan Y, Hsieh Y, Lin P
World J Surg. 2007; 31(5):1121-8.
PMID: 17429564
DOI: 10.1007/s00268-006-0783-0.
p53-expressing conditionally replicative adenovirus CNHK500-p53 against hepatocellular carcinoma in vitro.
Zhao H, Zhang Q, Yang Y, Lu M, Li H, Xu C
World J Gastroenterol. 2007; 13(5):683-91.
PMID: 17278190
PMC: 4066000.
DOI: 10.3748/wjg.v13.i5.683.
Telomerase activity, estrogen receptors (alpha, beta), Bcl-2 expression in human breast cancer and treatment response.
Murillo-Ortiz B, Astudillo-de la Vega H, Castillo-Medina S, Malacara J, Benitez-Bribiesca L
BMC Cancer. 2006; 6:206.
PMID: 16911782
PMC: 1562436.
DOI: 10.1186/1471-2407-6-206.
Difference in hTERT gene expressions between HbsAg-positive and HbsAg-negative hepatocellular carcinoma.
Guo Y, Zhou X, Liu E, Li X, Liu J, Yang Z
J Huazhong Univ Sci Technolog Med Sci. 2005; 25(3):303-6.
PMID: 16201279
DOI: 10.1007/BF02828150.
Large scaled analysis of hepatitis B virus (HBV) DNA integration in HBV related hepatocellular carcinomas.
Murakami Y, Saigo K, Takashima H, Minami M, Okanoue T, Brechot C
Gut. 2005; 54(8):1162-8.
PMID: 16009689
PMC: 1774867.
DOI: 10.1136/gut.2004.054452.
Modulation of human telomerase reverse transcriptase in hepatocellular carcinoma.
Chen C, Kyo S, Liu Y, Cheng Y, Hsieh C, Chan D
World J Gastroenterol. 2004; 10(5):638-42.
PMID: 14991929
PMC: 4716900.
DOI: 10.3748/wjg.v10.i5.638.